$APYX
Apyx Medical Corp Stock $apyx

$apyx Overview Financials Valuation SEC Filings Company Website

2022 Q3 Form 10-Q Financial Statement

#000071913522000063 Filed on August 11, 2022

Income Statement

Concept	2022 Q3	2022 Q2	2021 Q4
Revenue	$9.114M	$10.29M	$16.82M
YoY Change	-22.97%	-8.3%	46.81%
Cost Of Revenue	$3.357M	$3.378M	$4.673M
YoY Change	-11.07%	-8.46%	24.28%
Gross Profit	$5.757M	$6.914M	$12.15M
YoY Change	-28.54%	-8.23%	57.81%
Gross Profit Margin	63.17%	67.18%	72.22%
Selling, General & Admin	$4.671M	$4.539M	$12.90M
YoY Change	1.3%	6.52%	45.88%
% of Gross Profit	81.14%	65.65%	106.13%
Research & Development	$1.061M	$1.070M	$947.0K
YoY Change	-9.7%	-1.29%	2.93%
% of Gross Profit	18.43%	15.48%	7.79%
Depreciation & Amortization	$216.0K	$247.0K	$229.0K
YoY Change	-7.69%	17.62%	-0.43%
% of Gross Profit	3.75%	3.57%	1.88%
Operating Expenses	$11.54M	$12.89M	$13.84M
YoY Change	-4.03%	11.34%	41.83%
Operating Profit	-$5.782M	-$5.976M	-$1.692M
YoY Change	45.72%	47.81%	-17.86%
Interest Expense	$1.000K	$3.000K	$1.000K
YoY Change	-66.67%	50.0%
% of Operating Profit
Other Income/Expense, Net	$37.00K	$622.0K	-$185.0K
YoY Change	-119.17%	528.28%	-242.31%
Pretax Income	-$5.745M	-$5.354M	-$1.876M
YoY Change	38.07%	35.75%	-2.29%
Income Tax	$50.00K	$96.00K	$134.0K
% Of Pretax Income
Net Earnings	-$5.764M	-$5.426M	-$2.003M
YoY Change	36.52%	34.11%	30.92%
Net Earnings / Revenue	-63.24%	-52.72%	-11.91%
Basic Earnings Per Share	-$0.17	-$0.16
Diluted Earnings Per Share	-$0.17	-$0.16	-$58.27K
COMMON SHARES
Basic Shares Outstanding	34.57M shares	34.46M shares	34.34M shares
Diluted Shares Outstanding	34.57M shares	34.46M shares

Balance Sheet

Concept	2022 Q3	2022 Q2	2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$14.83M	$20.06M	$30.87M
YoY Change	-51.99%	-42.13%	-26.32%
Cash & Equivalents	$14.83M	$20.06M	$30.87M
Short-Term Investments
Other Short-Term Assets	$2.774M	$2.770M	$1.926M
YoY Change	-6.5%	-23.37%	-31.21%
Inventory	$12.04M	$9.677M	$6.778M
Prepaid Expenses
Receivables	$9.094M	$10.34M	$13.04M
Other Receivables	$19.00K	$33.00K	$483.0K
Total Short-Term Assets	$46.31M	$50.53M	$60.74M
YoY Change	-22.66%	-17.95%	-8.1%
LONG-TERM ASSETS
Property, Plant & Equipment	$6.810M	$6.842M	$6.575M
YoY Change	6.21%	5.73%	0.52%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$1.253M	$1.269M	$1.110M
YoY Change	18.77%	22.85%	37.55%
Total Long-Term Assets	$8.961M	$8.946M	$7.984M
YoY Change	13.53%	11.62%	-0.47%
TOTAL ASSETS
Total Short-Term Assets	$46.31M	$50.53M	$60.74M
Total Long-Term Assets	$8.961M	$8.946M	$7.984M
Total Assets	$55.27M	$59.47M	$68.72M
YoY Change	-18.45%	-14.55%	-7.27%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.070M	$2.587M	$2.631M
YoY Change	-32.0%	-7.57%	74.12%
Accrued Expenses	$5.913M	$5.889M	$10.29M
YoY Change	-10.94%	-1.24%	41.34%
Deferred Revenue			$533.0K
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$42.00K	$85.00K	$165.0K
YoY Change	-80.73%	-62.22%	-17.5%
Total Short-Term Liabilities	$11.19M	$11.35M	$13.21M
YoY Change	-4.41%	5.65%	44.27%
LONG-TERM LIABILITIES
Long-Term Debt	$78.00K	$93.00K	$18.00K
YoY Change	254.55%	22.37%	-91.0%
Other Long-Term Liabilities	$133.0K	$142.0K	$166.0K
YoY Change	-8.9%	-2.07%	0.0%
Total Long-Term Liabilities	$133.0K	$142.0K	$166.0K
YoY Change	-8.9%	-2.07%	0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$11.19M	$11.35M	$13.21M
Total Long-Term Liabilities	$133.0K	$142.0K	$166.0K
Total Liabilities	$13.05M	$13.31M	$14.71M
YoY Change	-0.44%	11.69%	43.5%
SHAREHOLDERS EQUITY
Retained Earnings	-$29.69M	-$23.92M	-$12.55M
YoY Change	181.44%	278.15%	-578.86%
Common Stock	$35.00K	$34.00K	$34.00K
YoY Change	2.94%	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$41.99M	$45.91M	$53.70M
YoY Change
Total Liabilities & Shareholders Equity	$55.27M	$59.47M	$68.72M
YoY Change	-18.45%	-14.55%	-7.27%

Cashflow Statement

Concept	2022 Q3	2022 Q2	2021 Q4
OPERATING ACTIVITIES
Net Income	-$5.764M	-$5.426M	-$2.003M
YoY Change	36.52%	34.11%	30.92%
Depreciation, Depletion And Amortization	$216.0K	$247.0K	$229.0K
YoY Change	-7.69%	17.62%	-0.43%
Cash From Operating Activities	-$5.360M	-$5.872M	$214.0K
YoY Change	48.68%	17.25%	-120.98%
INVESTING ACTIVITIES
Capital Expenditures	-$188.0K	-$401.0K	-$332.0K
YoY Change	10.59%	1193.55%	-14.87%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$188.0K	-$401.0K	-$332.0K
YoY Change	10.59%	1193.55%	-14.87%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	127.0K	2.000K	-39.00K
YoY Change	-484.85%	-98.72%	-70.0%
NET CHANGE
Cash From Operating Activities	-5.360M	-5.872M	214.0K
Cash From Investing Activities	-188.0K	-401.0K	-332.0K
Cash From Financing Activities	127.0K	2.000K	-39.00K
Net Change In Cash	-5.421M	-6.271M	-157.0K
YoY Change	42.36%	28.43%	-89.81%
FREE CASH FLOW
Cash From Operating Activities	-$5.360M	-$5.872M	$214.0K
Capital Expenditures	-$188.0K	-$401.0K	-$332.0K
Free Cash Flow	-$5.172M	-$5.471M	$546.0K
YoY Change	50.57%	9.93%	-186.67%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0000719135
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	0-12183
	dei	Entity Registrant Name EntityRegistrantName	APYX MEDICAL CORPORATION
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	11-2644611
	dei	Entity Address Address Line1 EntityAddressAddressLine1	5115 Ulmerton Road,
	dei	Entity Address City Or Town EntityAddressCityOrTown	Clearwater
	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	33760
	dei	City Area Code CityAreaCode	727
	dei	Local Phone Number LocalPhoneNumber	384-2323
	dei	Security12b Title Security12bTitle	Common Stock
	dei	Trading Symbol TradingSymbol	APYX
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	34573034	shares
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	20063000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	30870000	usd
	apyx	Stock Issued During Period Shares Stock Swaps StockIssuedDuringPeriodSharesStockSwaps	26027	shares
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	629000	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	430000	usd
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	10340000	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	13038000	usd
CY2022Q2	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	7642000	usd
CY2021Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	7642000	usd
CY2022Q2	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	33000	usd
CY2021Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	483000	usd
CY2022Q2	apyx	Provision For Obsolescence Inventory ProvisionForObsolescenceInventory	360000	usd
CY2021Q4	apyx	Provision For Obsolescence Inventory ProvisionForObsolescenceInventory	263000	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	9677000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	6778000	usd
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2770000	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1926000	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	50525000	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	60737000	usd
CY2022Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	5245000	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	5316000	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6842000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6575000	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	659000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	121000	usd
CY2022Q2	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	176000	usd
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	178000	usd
CY2022Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1269000	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1110000	usd
CY2022Q2	us-gaap	Assets Assets	59471000	usd
CY2021Q4	us-gaap	Assets Assets	68721000	usd
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	2587000	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2631000	usd
CY2022Q2	apyx	Accrued Liabilities And Other Liabilities Current AccruedLiabilitiesAndOtherLiabilitiesCurrent	8570000	usd
CY2021Q4	apyx	Accrued Liabilities And Other Liabilities Current AccruedLiabilitiesAndOtherLiabilitiesCurrent	10287000	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	110000	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	122000	usd
CY2022Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	85000	usd
CY2021Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	165000	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	11352000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	13205000	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	514000	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	0	usd
CY2022Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	93000	usd
CY2021Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	18000	usd
CY2022Q2	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	1207000	usd
CY2021Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	1323000	usd
CY2022Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	142000	usd
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	166000	usd
CY2022Q2	us-gaap	Liabilities Liabilities	13308000	usd
CY2021Q4	us-gaap	Liabilities Liabilities	14712000	usd
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	75000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	75000000	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	34493085	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	34493085	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	34409912	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	34409912	shares
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	34000	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	34000	usd
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	69793000	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	66221000	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-23922000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-12551000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	45905000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	53704000	usd
CY2022Q2	us-gaap	Minority Interest MinorityInterest	258000	usd
CY2021Q4	us-gaap	Minority Interest MinorityInterest	305000	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	46163000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	54009000	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	59471000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	68721000	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	10292000	usd
CY2021Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	11224000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	22785000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	19862000	usd
CY2022Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	3378000	usd
CY2021Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	3690000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	7652000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	6468000	usd
CY2022Q2	us-gaap	Gross Profit GrossProfit	6914000	usd
CY2021Q2	us-gaap	Gross Profit GrossProfit	7534000	usd
	us-gaap	Gross Profit GrossProfit	15133000	usd
	us-gaap	Gross Profit GrossProfit	13394000	usd
CY2022Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1070000	usd
CY2021Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1084000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2228000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2199000	usd
CY2022Q2	us-gaap	Professional Fees ProfessionalFees	2389000	usd
CY2021Q2	us-gaap	Professional Fees ProfessionalFees	1889000	usd
	us-gaap	Professional Fees ProfessionalFees	4675000	usd
	us-gaap	Professional Fees ProfessionalFees	3410000	usd
CY2022Q2	us-gaap	Salaries And Wages SalariesAndWages	4892000	usd
CY2021Q2	us-gaap	Salaries And Wages SalariesAndWages	4343000	usd
	us-gaap	Salaries And Wages SalariesAndWages	10073000	usd
	us-gaap	Salaries And Wages SalariesAndWages	8588000	usd
CY2022Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4539000	usd
CY2021Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4261000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	10004000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	7985000	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	12890000	usd
CY2021Q2	us-gaap	Operating Expenses OperatingExpenses	11577000	usd
	us-gaap	Operating Expenses OperatingExpenses	26980000	usd
	us-gaap	Operating Expenses OperatingExpenses	22182000	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-5976000	usd
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-4043000	usd
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.020
	us-gaap	Operating Income Loss OperatingIncomeLoss	-11847000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-8788000	usd
CY2022Q2	us-gaap	Interest Income Operating InterestIncomeOperating	18000	usd
CY2021Q2	us-gaap	Interest Income Operating InterestIncomeOperating	4000	usd
	us-gaap	Interest Income Operating InterestIncomeOperating	20000	usd
	us-gaap	Interest Income Operating InterestIncomeOperating	7000	usd
CY2022Q2	us-gaap	Interest Expense InterestExpense	3000	usd
CY2021Q2	us-gaap	Interest Expense InterestExpense	2000	usd
	us-gaap	Interest Expense InterestExpense	11000	usd
	us-gaap	Interest Expense InterestExpense	6000	usd
CY2022Q2	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	607000	usd
CY2021Q2	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	97000	usd
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	586000	usd
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	4000	usd
CY2022Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	622000	usd
CY2021Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	99000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	595000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	5000	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-5354000	usd
CY2021Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3944000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-11252000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-8783000	usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	96000	usd
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	107000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	166000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	173000	usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	-5450000	usd
CY2021Q2	us-gaap	Profit Loss ProfitLoss	-4051000	usd
	us-gaap	Profit Loss ProfitLoss	-11418000	usd
	us-gaap	Profit Loss ProfitLoss	-8956000	usd
CY2022Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-24000	usd
CY2021Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-5000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-47000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-9000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-5426000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-4046000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-11371000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-8947000	usd
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.16
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.16
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.12
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.12
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.33
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.33
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.26
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.26
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	60169000	usd
CY2021Q2	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	195000	usd
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1369000	usd
CY2021Q2	us-gaap	Profit Loss ProfitLoss	-4051000	usd
CY2021Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	57682000	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	49843000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	56000	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1714000	usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	-5450000	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	46163000	usd
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	63859000	usd
	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	195000	usd
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	21000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2563000	usd
	us-gaap	Profit Loss ProfitLoss	-8956000	usd
CY2021Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	57682000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	54009000	usd
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	208000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3364000	usd
	us-gaap	Profit Loss ProfitLoss	-11418000	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	46163000	usd
	us-gaap	Profit Loss ProfitLoss	-11418000	usd
	us-gaap	Profit Loss ProfitLoss	-8956000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	472000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	440000	usd
	apyx	Provision For Inventory Obsolescence ProvisionForInventoryObsolescence	139000	usd
	apyx	Provision For Inventory Obsolescence ProvisionForInventoryObsolescence	13000	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-47000	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	3364000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	2563000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	284000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	46000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2236000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	656000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	549000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1160000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	3187000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1198000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	33000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1296000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-1811000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	554000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-10390000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-7058000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	680000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	221000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-680000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-221000	usd
	apyx	Proceeds From Stock Options Exercised And Warrants Exercised ProceedsFromStockOptionsExercisedAndWarrantsExercised	208000	usd
	apyx	Proceeds From Stock Options Exercised And Warrants Exercised ProceedsFromStockOptionsExercisedAndWarrantsExercised	21000	usd
	apyx	Repaymentof Finance Lease Liabilities RepaymentofFinanceLeaseLiabilities	108000	usd
	apyx	Repaymentof Finance Lease Liabilities RepaymentofFinanceLeaseLiabilities	120000	usd
	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	0	usd
	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	195000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	100000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	96000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	163000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-62000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-10807000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-7245000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	30870000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	41915000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	20063000	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	34670000	usd
	us-gaap	Interest Paid Net InterestPaidNet	11000	usd
	us-gaap	Interest Paid Net InterestPaidNet	4000	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	8000	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	13000	usd
	apyx	Capitalization Of Lease Non Cash CapitalizationOfLeaseNonCash	600000	usd
	apyx	Capitalization Of Lease Non Cash CapitalizationOfLeaseNonCash	0	usd
	apyx	Capitalization Of Lease Execution CapitalizationOfLeaseExecution	103000	usd
	apyx	Capitalization Of Lease Execution CapitalizationOfLeaseExecution	0	usd
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reclassifications</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have reclassified certain amounts presented in the prior period to conform to the current period presentation. These reclassifications had no impact on previously reported net loss, retained earnings or net cash used in operating activities for the periods presented.</span></div>
CY2022Q2	us-gaap	Lessee Operating Lease Renewal Term LesseeOperatingLeaseRenewalTerm	P5Y
CY2022Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	4547000	usd
CY2021Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	3603000	usd
CY2018Q3	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	97000000	usd
CY2022Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	2192000	usd
CY2021Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	1441000	usd
CY2022Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	3298000	usd
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	1997000	usd
CY2022Q2	us-gaap	Inventory Gross InventoryGross	10037000	usd
CY2021Q4	us-gaap	Inventory Gross InventoryGross	7041000	usd
CY2022Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	360000	usd
CY2021Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	263000	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	9677000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	6778000	usd
CY2022Q2	us-gaap	Lessee Finance Lease Term Of Contract1 LesseeFinanceLeaseTermOfContract1	P63M
CY2022Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y6M
CY2022Q2	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P3Y2M12D
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y
CY2021Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P0Y9M18D
CY2022Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0183
CY2022Q2	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0304
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0398
CY2021Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0400
CY2022Q2	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	185000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	32000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	61000	usd
CY2022Q2	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	70000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	119000	usd
CY2022Q2	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	40000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	119000	usd
CY2022Q2	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	21000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	119000	usd
CY2022Q2	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	21000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	119000	usd
CY2022Q2	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	21000	usd
CY2022Q2	apyx	Lessee Operating Lease Liability To Be Paid Due After Year Four LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour	119000	usd
CY2022Q2	apyx	Finance Lease Liability To Be Paid Due After Year Four FinanceLeaseLiabilityToBePaidDueAfterYearFour	12000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	656000	usd
CY2022Q2	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	7000	usd
CY2022Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	624000	usd
CY2022Q2	us-gaap	Finance Lease Liability FinanceLeaseLiability	178000	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	110000	usd
CY2022Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	85000	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	514000	usd
CY2022Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	93000	usd
CY2022Q2	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	621000	usd
CY2021Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	546000	usd
CY2022Q2	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	802000	usd
CY2021Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	2117000	usd
CY2022Q2	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	1074000	usd
CY2021Q4	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	1656000	usd
CY2022Q2	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	611000	usd
CY2021Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	593000	usd
CY2022Q2	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	597000	usd
CY2021Q4	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	610000	usd
CY2022Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1091000	usd
CY2021Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	421000	usd
CY2022Q2	apyx	Joint And Several Payroll Liability JointAndSeveralPayrollLiability	405000	usd
CY2021Q4	apyx	Joint And Several Payroll Liability JointAndSeveralPayrollLiability	1027000	usd
CY2022Q2	apyx	Short Term Contract Liabilities ShortTermContractLiabilities	821000	usd
CY2021Q4	apyx	Short Term Contract Liabilities ShortTermContractLiabilities	533000	usd
CY2022Q2	apyx	Uncertain Tax Positions Liability UncertainTaxPositionsLiability	1970000	usd
CY2021Q4	apyx	Uncertain Tax Positions Liability UncertainTaxPositionsLiability	1863000	usd
CY2022Q2	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	143000	usd
CY2021Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	428000	usd
CY2022Q2	apyx	Other Accrued Expenses And Liabilities Current OtherAccruedExpensesAndLiabilitiesCurrent	435000	usd
CY2021Q4	apyx	Other Accrued Expenses And Liabilities Current OtherAccruedExpensesAndLiabilitiesCurrent	493000	usd
CY2022Q2	apyx	Accrued Liabilities And Other Liabilities Current AccruedLiabilitiesAndOtherLiabilitiesCurrent	8570000	usd
CY2021Q4	apyx	Accrued Liabilities And Other Liabilities Current AccruedLiabilitiesAndOtherLiabilitiesCurrent	10287000	usd
CY2022Q2	apyx	Joint And Several Payroll Liability JointAndSeveralPayrollLiability	-650000	usd
CY2022Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-5426000	usd
CY2022Q2	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-5426000	usd
CY2021Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-4046000	usd
CY2021Q2	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-4046000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-11371000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-11371000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-8947000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-8947000	usd
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	34464000	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	34464000	shares
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	34321000	shares
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	34321000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	34447000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	34447000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	34312000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	34312000	shares
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.16
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.16
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.12
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.12
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.33
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.33
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.26
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.26
CY2022Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1714000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3364000	usd
CY2021Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1369000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2563000	usd
	apyx	Stock Issued During Period Shares Stock Swaps Equity Instruments Received StockIssuedDuringPeriodSharesStockSwapsEquityInstrumentsReceived	36667	shares
	apyx	Stock Issued During Period Shares Stock Swaps Equity Instruments Received StockIssuedDuringPeriodSharesStockSwapsEquityInstrumentsReceived	22055	shares
	apyx	Stock Issued During Period Shares Stock Swaps StockIssuedDuringPeriodSharesStockSwaps	39000	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	5397691	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	5.95
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1478419	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	10.96
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	119840	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	4.46
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	76997	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	9.81
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	6679273	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	7.04
CY2022Q2	apyx	Stock Issued During Period Shares Stock Swaps Equity Instruments Received StockIssuedDuringPeriodSharesStockSwapsEquityInstrumentsReceived	14013	shares
CY2021Q2	apyx	Stock Issued During Period Shares Stock Swaps Equity Instruments Received StockIssuedDuringPeriodSharesStockSwapsEquityInstrumentsReceived	6614	shares
CY2022Q2	apyx	Stock Issued During Period Shares Stock Swaps StockIssuedDuringPeriodSharesStockSwaps	19987	shares
CY2021Q2	apyx	Stock Issued During Period Shares Stock Swaps StockIssuedDuringPeriodSharesStockSwaps	4886	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	10.96
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.016
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.696
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	96000	usd
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	107000	usd
CY2022Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.018
CY2021Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.027
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	166000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	173000	usd
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.015
CY2022Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1313000	usd
CY2022Q2	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	657000	usd
CY2022Q2	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	53000	usd
CY2021Q2	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	51000	usd
	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	105000	usd
	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	99000	usd
CY2022Q2	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	1970000	usd
CY2022Q2	us-gaap	Purchase Obligation PurchaseObligation	5600000	usd
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	segment
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	10292000	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-5976000	usd
CY2022Q2	us-gaap	Interest Income Operating InterestIncomeOperating	18000	usd
CY2022Q2	us-gaap	Interest Expense InterestExpense	3000	usd
CY2022Q2	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	607000	usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	96000	usd
CY2021Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	11224000	usd
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-4043000	usd
CY2021Q2	us-gaap	Interest Income Operating InterestIncomeOperating	4000	usd
CY2021Q2	us-gaap	Interest Expense InterestExpense	2000	usd
CY2021Q2	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	97000	usd
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	107000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	22785000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-11847000	usd
	us-gaap	Interest Income Operating InterestIncomeOperating	20000	usd
	us-gaap	Interest Expense InterestExpense	11000	usd
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	586000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	166000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	19862000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-8788000	usd
	us-gaap	Interest Income Operating InterestIncomeOperating	7000	usd
	us-gaap	Interest Expense InterestExpense	6000	usd
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	4000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	173000	usd
CY2022Q2	apyx	Total Revenue Percent TotalRevenuePercent	0.228
	apyx	Total Revenue Percent TotalRevenuePercent	0.320
CY2021Q2	apyx	Total Revenue Percent TotalRevenuePercent	0.342
	apyx	Total Revenue Percent TotalRevenuePercent	0.348
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	10292000	usd
CY2021Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	11224000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	22785000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	19862000	usd

Files In Submission

Name	View Source	Status
0000719135-22-000063-index-headers.html	Edgar Link	pending
0000719135-22-000063-index.html	Edgar Link	pending
0000719135-22-000063.txt	Edgar Link	pending
0000719135-22-000063-xbrl.zip	Edgar Link	pending
a2022q210-qexhibit311.htm	Edgar Link	pending
a2022q210-qexhibit312.htm	Edgar Link	pending
a2022q210-qexhibit321.htm	Edgar Link	pending
a2022q210-qexhibit322.htm	Edgar Link	pending
apyx-20220630.htm	Edgar Link	pending
apyx-20220630.xsd	Edgar Link	pending
apyx-20220630_g1.jpg	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
apyx-20220630_def.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
apyx-20220630_pre.xml	Edgar Link	unprocessable
apyx-20220630_htm.xml	Edgar Link	completed
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
apyx-20220630_cal.xml	Edgar Link	unprocessable
apyx-20220630_lab.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$APYX
Apyx Medical Corp Stock $apyx

2022 Q3 Form 10-Q Financial Statement

#000071913522000063 Filed on August 11, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$APYX Apyx Medical Corp Stock $apyx

2022 Q3 Form 10-Q Financial Statement

#000071913522000063 Filed on August 11, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$APYX
Apyx Medical Corp Stock $apyx